136 related articles for article (PubMed ID: 18505397)
1. Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens.
Lebeis SL; Sherman MA; Kalman D
Future Microbiol; 2008 Jun; 3(3):315-28. PubMed ID: 18505397
[TBL] [Abstract][Full Text] [Related]
2. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium.
Lebeis SL; Bommarius B; Parkos CA; Sherman MA; Kalman D
J Immunol; 2007 Jul; 179(1):566-77. PubMed ID: 17579078
[TBL] [Abstract][Full Text] [Related]
3. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.
Pallett MA; Crepin VF; Serafini N; Habibzay M; Kotik O; Sanchez-Garrido J; Di Santo JP; Shenoy AR; Berger CN; Frankel G
Mucosal Immunol; 2017 May; 10(3):602-612. PubMed ID: 27624779
[TBL] [Abstract][Full Text] [Related]
4. Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.
Silberger DJ; Zindl CL; Weaver CT
Mucosal Immunol; 2017 Sep; 10(5):1108-1117. PubMed ID: 28612839
[TBL] [Abstract][Full Text] [Related]
5. Attaching and effacing pathogens: the effector ABC of immune subversion.
Riebisch AK; Mühlen S
Future Microbiol; 2020 Jul; 15():945-958. PubMed ID: 32716209
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.
Lebeis SL; Powell KR; Merlin D; Sherman MA; Kalman D
Infect Immun; 2009 Feb; 77(2):604-14. PubMed ID: 19075023
[TBL] [Abstract][Full Text] [Related]
7. Citrobacter rodentium: infection, inflammation and the microbiota.
Collins JW; Keeney KM; Crepin VF; Rathinam VA; Fitzgerald KA; Finlay BB; Frankel G
Nat Rev Microbiol; 2014 Sep; 12(9):612-23. PubMed ID: 25088150
[TBL] [Abstract][Full Text] [Related]
8. Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.
Khan MA; Bouzari S; Ma C; Rosenberger CM; Bergstrom KS; Gibson DL; Steiner TS; Vallance BA
Infect Immun; 2008 Apr; 76(4):1410-22. PubMed ID: 18227166
[TBL] [Abstract][Full Text] [Related]
9. TLR9 limits enteric antimicrobial responses and promotes microbiota-based colonisation resistance during Citrobacter rodentium infection.
Yang H; Yu HB; Bhinder G; Ryz NR; Lee J; Yang H; Fotovati A; Gibson DL; Turvey SE; Reid GS; Vallance BA
Cell Microbiol; 2019 Jul; 21(7):e13026. PubMed ID: 30893495
[TBL] [Abstract][Full Text] [Related]
10. Innate immunity restricts Citrobacter rodentium A/E pathogenesis initiation to an early window of opportunity.
Buschor S; Cuenca M; Uster SS; Schären OP; Balmer ML; Terrazos MA; Schürch CM; Hapfelmeier S
PLoS Pathog; 2017 Jun; 13(6):e1006476. PubMed ID: 28662171
[TBL] [Abstract][Full Text] [Related]
11. Linking Pathogen Virulence, Host Immunity and The Microbiota at the Intestinal Barrier.
Nunez G
Keio J Med; 2017; 66(1):14. PubMed ID: 28356548
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.
Khan MA; Ma C; Knodler LA; Valdez Y; Rosenberger CM; Deng W; Finlay BB; Vallance BA
Infect Immun; 2006 May; 74(5):2522-36. PubMed ID: 16622187
[TBL] [Abstract][Full Text] [Related]
13. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
El Qaidi S; Wu M; Zhu C; Hardwidge PR
Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
[TBL] [Abstract][Full Text] [Related]
14. Citrobacter rodentium mouse model of bacterial infection.
Crepin VF; Collins JW; Habibzay M; Frankel G
Nat Protoc; 2016 Oct; 11(10):1851-76. PubMed ID: 27606775
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.
Zheng Y; Valdez PA; Danilenko DM; Hu Y; Sa SM; Gong Q; Abbas AR; Modrusan Z; Ghilardi N; de Sauvage FJ; Ouyang W
Nat Med; 2008 Mar; 14(3):282-9. PubMed ID: 18264109
[TBL] [Abstract][Full Text] [Related]
16. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.
Chen CC; Louie S; McCormick B; Walker WA; Shi HN
Infect Immun; 2005 Sep; 73(9):5468-81. PubMed ID: 16113263
[TBL] [Abstract][Full Text] [Related]
17. Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner.
Jain U; Cao Q; Thomas NA; Woodruff TM; Schwaeble WJ; Stover CM; Stadnyk AW
J Immunol; 2015 Apr; 194(7):3414-21. PubMed ID: 25725105
[TBL] [Abstract][Full Text] [Related]
18. HOIL1 Regulates Group 3 Innate Lymphoid Cells in the Colon and Protects against Systemic Dissemination, Colonic Ulceration, and Lethality from Citrobacter rodentium Infection.
Hartley VL; Qaqish AM; Wood MJ; Studnicka BT; Iwai K; Liu TC; MacDuff DA
J Immunol; 2023 Dec; 211(12):1823-1834. PubMed ID: 37902285
[TBL] [Abstract][Full Text] [Related]
19. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals.
Xia X; Liu Y; Hodgson A; Xu D; Guo W; Yu H; She W; Zhou C; Lan L; Fu K; Vallance BA; Wan F
PLoS Pathog; 2019 Jun; 15(6):e1007898. PubMed ID: 31251784
[TBL] [Abstract][Full Text] [Related]
20. CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen.
Reid-Yu SA; Small CL; Coombes BK
Eur J Immunol; 2013 Oct; 43(10):2638-49. PubMed ID: 23775576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
